5 documents

Read All
08:00 , Dec 16, 2013 |  BC Week In Review  |  Company News

Cardax Pharmaceuticals, Koffee Korner deal

Cardax's Cardax Pharma Inc. subsidiary will reverse-merge with food and beverage company Koffee Korner in a stock deal. The merger is subject to several conditions, including the divesture of Koffee Korner's existing business. The surviving...
Read More
07:00 , Jun 1, 2009 |  BC Week In Review  |  Company News

Cardax management update

Cardax Pharmaceuticals Inc. , Aiea, Hawaii   Business: Inflammation, Cardiovascular   Hired: Gilbert Rishton as CSO, currently director of Channel Islands Alzheimer's Institute  ...
Read More
08:00 , Dec 11, 2006 |  BC Week In Review  |  Company News

Cardax, BASF deal

BF will exclusively manufacture a derivative of astaxanthin, an intermediate used to make Cardax's Xancor, which is in preclinical testing to treat cardiovascular inflammatory disease. BF also received an option to a royalty-bearing license for...
Read More
07:00 , Oct 16, 2006 |  BC Week In Review  |  Company News

Cardax management update

Cardax Pharmaceuticals Inc. , Aiea, Hawaii   Business: Inflammation, Cardiovascular   Hired: Fred Pashkow as EVP and CMO, formerly VP of U.S. medical affairs for the cardiovascular and thrombosis therapeutic area at sanofi-aventis Group  ...
Read More
07:00 , Sep 26, 2005 |  BC Week In Review  |  Company News

Hawaii Bio inflammation, cardiovascular, infectious news

Hawaii Biotech Inc. , Aiea, Hawaii   Business: Inflammation, Cardiovascular, Infectious   Hawaii restructured and will reduce its headcount by 20%, from 70 to 56. Hawaii will focus its resources to develop three preclinical compounds:...
Read More